Skip to main content
Clinical Trials/ITMCTR1900002523
ITMCTR1900002523RecruitingPhase 1

Effects of edaravone on early postoperative cognitive function in elderly patients undergoing hip joint replacement surgery

Shanghai Pudong Hospital0 sitesStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • Patients aged 60 years and over; received hip joint replacement surgery; informed consent; ASA I or II.

Exclusion Criteria

  • History of psychiatric disorders, cerebrovascular diseases and diabetes; long term use of nervous and mental system drugs (such as sedative hypnotics and antidepressants); history of alcohol abuse; severe impairment on speaking, hearing and vision that difficult to communicate; MMSE score < 23 one day before surgery.

Investigators

Sponsor
Shanghai Pudong Hospital

Similar Trials